Gut Bacteria Reactivity Linked to IgA Nephropathy
A new study finds patients with IgA nephropathy show heightened immune responses to several intestinal bacterial species compared with healthy individuals.
Updated on Nov. 3, 2026 in Nutrition
Patients with immunoglobulin A nephropathy show greater serum IgA reactivity to several intestinal bacteria than healthy controls, according to research being presented at ASN Kidney Week 2026. Researchers measured these responses using an enzyme-linked immunosorbent assay.
Why it matters
Previous research has suggested that shifts in the gut microbiota may contribute to the production of pathogenic IgA, a potential link the findings help explore. The results support continued investigation of therapies targeting mucosal immune pathways.
The analysis compared biopsy-confirmed IgAN patients at diagnosis against healthy controls, with four species showing differences at P<0.001. Serum secretory IgA concentrations were positively correlated with reactivity to Flavonifractor plautii (P=0.002), Bifidobacterium longum (P=0.003), and Akkermansia muciniphila (P=0.004), but the study's causal direction remains unresolved.
The players
American Society of Nephrology
The American Society of Nephrology is a professional organization of kidney specialists that hosts the annual Kidney Week conference where this research is being presented.
The details
Researchers measured serum IgA reactivity to bacterial antigens in IgAN patients and healthy controls using an enzyme-linked immunosorbent assay. They also assessed serum secretory IgA concentrations and their association with responses to individual bacterial species.
Timeline
The study was published on November 3, 2026, ahead of its presentation at ASN Kidney Week 2026.
Big Picture
The findings extend earlier research linking gut microbiota shifts to pathogenic IgA production, presented at the American Society of Nephrology's Kidney Week 2026. They fit a growing body of work examining whether mucosal immune pathways in the gut could become targets for IgA nephropathy treatment.
For readers concerned about kidney health, the research points toward gut-based immune pathways as a possible future area for treatment rather than an immediate change in care. The findings do not establish dietary changes as a means of preventing or managing IgA nephropathy.
The takeaway
The research suggests the intestinal microbiome may play a role in IgA nephropathy, though whether it drives the disease remains to be determined by future studies.
Further reading
Explore more on the gut-kidney connection in our Nutrition section.
Source note: This article includes information reported by Derm Immuno Today.
